Bioinformatic Analysis of Prognostic Value of SNTG2 with Immune Implications in Lung Adenocarcinoma

BACKGROUND: Lung cancer is the most morbid and fatal cancer in the world, and nearly 85% of lung cancer is non-small cell lung cancer (NSCLC). Besides traditional chemotherapies, molecular targeted therapies and immunotherapies are increasing rapidly, but the treatment is still unsatisfactory. The s...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian, Wen, Yang, Chen, Xiangtian, Guo, Linlang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148212/
https://www.ncbi.nlm.nih.gov/pubmed/35637702
http://dx.doi.org/10.2147/IJGM.S355393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148212/
https://www.ncbi.nlm.nih.gov/pubmed/35637702
http://dx.doi.org/10.2147/IJGM.S355393

Ejemplares similares